Arteris Inc has a consensus price target of $15, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from Jefferies, Rosenblatt, and Wedbush on May 13, 2024, May 3, 2024, and February 20, 2024. With an average price target of $13.67 between Jefferies, Rosenblatt, and Wedbush, there's an implied 89.55% upside for Arteris Inc from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/13/2024 | Buy Now | 24.83% | Jefferies | Blayne Curtis | $11 → $9 | Downgrade | Buy → Hold | Get Alert |
05/03/2024 | Buy Now | 108.04% | Rosenblatt | Hans Mosesmann | → $15 | Reiterates | Buy → Buy | Get Alert |
02/20/2024 | Buy Now | 135.78% | Wedbush | Jay McCanless | → $17 | Reiterates | Outperform → Outperform | Get Alert |
09/13/2023 | Buy Now | 191.26% | Rosenblatt | Hans Mosesmann | → $21 | Reiterates | Buy → Buy | Get Alert |
09/06/2023 | Buy Now | 94.17% | Northland Capital Markets | Gus Richard | $16 → $14 | Maintains | Outperform | Get Alert |
08/07/2023 | Buy Now | 191.26% | Rosenblatt | Hans Mosesmann | → $21 | Reiterates | Buy → Buy | Get Alert |
08/03/2023 | Buy Now | 191.26% | Rosenblatt | Hans Mosesmann | → $21 | Reiterates | Buy → Buy | Get Alert |
06/09/2023 | Buy Now | 191.26% | Rosenblatt | Hans Mosesmann | → $21 | Reiterates | Buy → Buy | Get Alert |
06/02/2023 | Buy Now | 121.91% | Northland Capital Markets | Gus Richard | → $16 | Reiterates | → Outperform | Get Alert |
03/02/2023 | Buy Now | 38.7% | TD Cowen | Matt Ramsay | $12 → $10 | Maintains | Outperform | Get Alert |
03/01/2023 | Buy Now | 121.91% | Northland Capital Markets | Gus Richard | $20 → $16 | Maintains | Outperform | Get Alert |
03/01/2023 | Buy Now | 191.26% | Rosenblatt | Hans Mosesmann | → $21 | Reiterates | → Buy | Get Alert |
11/09/2022 | Buy Now | -2.91% | BMO Capital | Ambrish Srivastava | $12 → $7 | Maintains | Market Perform | Get Alert |
08/10/2022 | Buy Now | 66.44% | BMO Capital | Ambrish Srivastava | $15 → $12 | Maintains | Market Perform | Get Alert |
08/10/2022 | Buy Now | 191.26% | Rosenblatt | Hans Mosesmann | $35 → $21 | Maintains | Buy | Get Alert |
11/22/2021 | Buy Now | 232.87% | BMO Capital | Ambrish Srivastava | — | Initiates | → Market Perform | Get Alert |
11/22/2021 | Buy Now | 357.7% | Jefferies | Mark Lipacis | — | Initiates | → Buy | Get Alert |
11/22/2021 | Buy Now | 274.48% | Northland Capital Markets | Gus Richard | — | Initiates | → Outperform | Get Alert |
11/22/2021 | Buy Now | 385.44% | Rosenblatt | Hans Mosesmann | — | Initiates | → Buy | Get Alert |
The latest price target for Arteris (NASDAQ:AIP) was reported by Jefferies on May 13, 2024. The analyst firm set a price target for $9.00 expecting AIP to rise to within 12 months (a possible 24.83% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Arteris (NASDAQ:AIP) was provided by Jefferies, and Arteris downgraded their hold rating.
There is no last upgrade for Arteris
The last downgrade for Arteris Inc happened on May 13, 2024 when Jefferies changed their price target from $11 to $9 for Arteris Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arteris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arteris was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.
While ratings are subjective and will change, the latest Arteris (AIP) rating was a downgraded with a price target of $11.00 to $9.00. The current price Arteris (AIP) is trading at is $7.21, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.